Greg yap

Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines
→
Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference
→
Our Investment in Cartwheel: Improving Youth Mental Health
→
Video: Building Riva With Menlo Labs
→
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
→
Video: Early Cancer Detection With Delfi
→
Video: Reengineering Drug Discovery With Recursion
→
Video: Fighting the Opioid Epidemic With Ophelia
→
Carefully Crafted Digital Approaches Can Improve Youths’ Mental Health Care
→
Announcing the Digital Health Founder’s Fellowship
→
Video: Improving Heart Health With Riva
→
Ophelia Health: Fighting the Opioid Epidemic by Making the Best Care Accessible
→
Life Science Is Being Transformed by Vertical SaaS
→

The 5 Ps of Therapeutics Investing at Menlo
→


We Are Hiring a Principal with Therapeutics Expertise: Building a Biotech Franchise at Menlo
→

Our Investment in Riva Health: Building the Future of Cardiovascular Healthcare
→

Doubling Down on H1: Menlo Co-Leads Series B, Eight Months After Leading Series A
→

Four Big Trends in Digital Health
→

Pliant and the 5 Ps of Therapeutics Investing at Menlo
→

Particle: Data Interoperability Powering the Future of Digital Healthcare
→

Investing in H1: SaaS Healthcare Analytics
→

Investing in Benchling: Software Accelerating Life Science Innovation
→

Menlo Ventures’ Greg Yap Selected for Aspen Institute’s Health Innovators Fellowship
→
